Our Story

About Preceptis Medical

Preceptis Medical was founded by parents, including a pediatric anesthesiologist, who wanted to design products focused on improving the lives of children. The Hummingbird Device was designed by the team in partnership with leading pediatric ENTs to simplify ear tube procedures and create options for the procedure to be done with less anesthesia.

Our goal is to broaden options available to ENTs and Parents, focusing on the safety and comfort of the child, while reducing health care costs.

Over 1 million children receive ear tubes each year in the United States, making it the most common pediatric procedure and the primary reason for exposure to general anesthesia in children under 3.

Long-term, we also believe the Hummingbird has the potential to impact the lives of children in developing countries. According to the World Health Organization, chronic otitis media is a leading cause of hearing loss for millions of children and adults in developing countries. For patients with limited or no access to antibiotics or surgical placement of ear tubes, the risk of developing permanent hearing loss is significant.

Meet Our Team

Steve Anderson

Co-Founder & CEO

Steve Anderson is the CEO and a co-founder of Preceptis. In his most recent experience, he was President of Acorn Cardiovascular, a medical device manufacturer developing therapies for treating heart failure. Steve has a BS in Materials Engineering and an MS in Biomedical Engineering from the University of Minnesota. He was an Adjunct Professor at the University of St. Thomas Graduate School and has served on multiple boards for medical device companies. Steve’s passion for pediatric medical devices is in part due to having a son (Noah) who was born with special needs (spina bifida).

Andreas Deibel

R&D And Operations

R. Andreas Deibel is in charge of Operations and Product Development for Preceptis. Prior to Preceptis, Andreas held design engineering, product development, and operations management roles at Augustine Biomedical and Arizant Healthcare (now part of 3M). He is inventor or co-inventor on numerous US and international patents. Andreas received his BA from Dartmouth College.

Joe Delgado

Finance & Healthcare Services

Joe Delgado is in charge of finance and healthcare services for Preceptis. Prior to Preceptis, Joe’s experiences include product development and management for UnitedHealth Care and Optum, corporate development and strategy for Optum, and M&A and Operations consulting at Deloitte Consulting. Joe is also on the board of a local Minnesota eCommerce company. Joe received his BS in Finance at the University of Minnesota and MBA from the Kellogg School of Management, Northwestern University.

Greg Mielke

Commercialization

Greg Mielke leads the commercialization efforts for Preceptis and brings over 18 years of senior leadership and sales experience within the medical device industry. His most recent experience serving as Vice President of Sales – West for Intersect ENT. He has held various leadership roles at Vertos Medical, Abbott Neuromodulation and Bard. He brings a strong balance of experiences, specifically in emerging and disruptive technologies. He currently holds a B.A in Anthropology from St. Cloud State University.

Our Global Impact

The Hummingbird has been designed to have a positive impact both near and far. Dr. Frank Rimell, Pediatric ENT, Cedars Sinai Medical Center, Medical Director for Preceptis says, “Hearing loss and deafness is a global health crisis, and the WHO estimates that 34 million children worldwide have disabling hearing loss. 75% of hearing loss in children in developing countries is preventable. I believe that the Hummingbird has the potential to make a significant impact in these countries due to the ability to address preventable causes of hearing loss (chronic otitis media) without a traditional operating room and general anesthesia.”

Board of Directors

John Seaberg

Preceptis Chairman of the Board, Executive Vice President, Cedar Point Capital

Buzz Benson

Managing Partner, Sightline Partners

 

 

Michael Loushin, MD

Preceptis Co-Founder, Pediatric Anesthesiologist, Partner, Twin Cities Anesthesia Associates, PA

David Overman

Former COO, Children’s Hospitals, Clinics of Minnesota & Prime Therapeutics

Chris Geyen

CFO, Relievant Medsystems

Feng Jiang, MD, PHD

Managing Partner, Brillimed Group

 

 

Connect With Hummingbird!

5 + 13 =

Office

10900 89th Avenue North, Suite #4, Maple Grove, MN 55369

Get In Touch With Us

(763) 568-7810  info@preceptismedical.com

Indications for Use: The Hummingbird® Tympanostomy Tube System (HTTS) is intended to deliver a tympanostomy tube (also referred to as a ventilation tube) through the tympanic membrane of the patient and is indicated to be used in office settings for children 6-24 months old.

62-1178-001A